Pentobarbital will reduce the extent or effect of fentanyl transmucosal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Coadministration of fentanyl with CYP3A4 inducers could lead to the decrease in fentanyl plasma concentrations, deficiency of efficacy or, perhaps, progress of the withdrawal syndrome within a affected person who may https://enricoj295qss3.ziblogs.com/profile